US NIH Testing Strategy To Stretch Monkeypox Vaccine Supply Even Further
Executive Summary
The National Institutes of Health is gearing up to launch a trial that would test a smaller intradermal dose of Jynneos than was recently given an emergency use authorization, which could double vaccine supplies relative to currently available intradermal dosing. The trial still will leave the efficacy question unanswered.